|
News
-
06.27.2023IAM Patent 1000 Recognizes Perkins Coie and 51 Lawyers as Patent Leaders in U.S. and AsiaPress ReleasesPerkins Coie is pleased to announce that 51 of its intellectual property (IP) lawyers in the United States and Asia were recognized by Intellectual Asset Management (IAM) in the 2023 IAM Patent 1000 list.
-
06.01.2023Perkins Coie Named Among Top Law Firms in 2023 Chambers USAPress ReleasesPerkins Coie is proud to announce that it has again been ranked by Chambers & Partners, publishers of Chambers USA: America’s Leading Lawyers for Business, as one of the top law firms in the United States.
-
10.11.2022Perkins Coie Attorneys Mentioned in Law360—Storage Co. Cleared Of Infringing In 'SpareSpace' TM FightGeneral NewsPerkins Coie attorneys Brandon White, Jeremy Buxbaum and Thomas Holt represented Storage Cap Management LP.
-
8.10.2022IAM Patent 1000 Recognizes Perkins Coie and 49 Firm Attorneys as Patent Leaders in U.S. and ChinaPress ReleasesPerkins Coie is pleased to announce that 49 of its intellectual property (IP) attorneys in the United States and Asia were recognized by Intellectual Asset Management (IAM) in the 2022 IAM Patent 1000 list, which recognizes the world’s leading, best-in-class patent professionals in patent prosecution, licensing, and litigation. The firm was also ranked nationally in the United States and China and internationally overall for patent litigation, prosecution, and post-grant proceedings.
-
06.01.2022Perkins Coie Named Among Top Law Firms in 2022 Chambers USAPress ReleasesPerkins Coie is proud to announce that it has again been ranked by Chambers & Partners, publishers of Chambers USA: America’s Leading Lawyers for Business, as one of the top law firms in the United States.
-
10.09.2021Brandon White Mentioned in Techbondhu—Bayer, Meda Sue Apotex Over Proposed Astepro Allergy GenericGeneral NewsBrandon White was mentioned in Techbondhu’s article, “Bayer, Meda Sue Apotex Over Proposed Astepro Allergy Generic,” regarding his representation of Meda Pharmaceuticals in a case against Canadian generic drugmaker Apotex.
-
08.04.2021IAM Patent 1000 Recognizes Perkins Coie and 46 Firm Attorneys as Patent Leaders in US and ChinaPress ReleasesPerkins Coie is pleased to announce that 44 of its intellectual property (IP) attorneys were recognized by Intellectual Asset Management (IAM) in the 2021 IAM Patent 1000 list, which recognizes the world’s leading, best-in-class patent professionals in patent prosecution, licensing, and litigation.
-
05.20.2021Perkins Coie Named Among Top Law Firms in 2021 Chambers USAPress ReleasesPerkins Coie is proud to announce that it has again been ranked by Chambers & Partners, publishers of Chambers USA: America’s Leading Lawyers for Business, as one of the top law firms in the United States.
-
03.11.2020Perkins Coie Mentioned in Law360 - Akerman Atty Gets Canned From Storage Co.'s TM SuitGeneral News
Law360
Jeremy Buxbaum, Thomas Holt and Brandon White were mentioned as counsel for Storage Cap Management LP in a Law360* article, "Akerman Atty Gets Canned From Storage Co.'s TM Suit," regarding Storage Cap's motion to disqualify an attorney and his law firm from a trademark intellectual property suit. -
09.09.2019Perkins Coie Recognized as a Leading Firm in 2019 IPR Intelligence ReportPress ReleasesPerkins Coie is pleased to announce that the firm and ten partners were recognized as leaders in inter partes review (“IPR”) in Patexia’s 2019 IPR Intelligence Report, an annual comprehensive report of IPR data and analysis over the last five years.
-
05.15.2019Brandon White Quoted in Law360 - The Do's and Don'ts of Extra Discovery at the PTABGeneral News
Law360
Brandon White was quoted in the Law360 article, "The Do's and Don'ts of Extra Discovery at the PTAB," regarding how to handle the discovery process with the Patent Trial and Appeal Board. -
10.29.2018Perkins Coie Attorneys Mentioned in Law360 - NJ Judge Invalidates Patent for Janssen Cancer Drug ZytigaGeneral NewsShannon M. Bloodworth, Brandon M. White, Maria A. Stubbings and Bryan D. Beel were mentioned as counsel for Mylan in the Law360* article, "NJ Judge Invalidates Patent for Janssen Cancer Drug Zytiga," regarding the invalidation of a patent that covered Janssen Biotech Inc.’s oncology medication, Zytiga.
*Subscription-based publication -
10.18.2018Perkins Coie Attorneys Mentioned in Law360 - Bristol-Myers, Pfizer's Blood Thinner IP Suit Axed Over VenueGeneral NewsShannon Bloodworth and Brandon White were mentioned as counsel for Mylan Pharmaceuticals Inc. in the Law360* article, "Bristol-Myers, Pfizer's Blood Thinner IP Suit Axed Over Venue," regarding the case against them getting thrown out due to being filed in the wrong venue.
*Subscription-based publication -
10.12.2018Perkins Coie Attorneys Mentioned in Law360 - Fed. Circ. Rules Teva's Copaxone Patents Are InvalidGeneral NewsDavid Anstaett, Shannon Bloodworth, Brandon White, Dan Bagatell, and Christina Jordan McCullough were mentioned in the Law360* article, "Fed. Circ. Rules Teva's Copaxone Patents Are Invalid," as representation for Mylan Pharmaceuticals Inc. Bloomberg also covered the decision in the article, "Teva Loses Appeal Over Four Patents for MS Drug Copaxone."
*Subscription-based publication -
10.12.2018Perkins Coie Client Win Reported by Mylan - Mylan Prevails in Copaxone® 40mg/mL Litigation Against Teva in U.S. Appellate CourtGeneral NewsPerkins Coie represented Mylan in its recent milestone Federal Circuit wins, relating to Glatiramer Acetate Injection 40mg/mL. The decision was reported in the Mylan article, "Mylan Prevails in Copaxone® 40mg/mL Litigation Against Teva in U.S. Appellate Court."
-
04.20.2018Perkins Coie Attorneys Noted as Counsel in the Law.com Article - Skilled in the Art: The Brave New World of Section 101 GuidanceGeneral News
Law.com
Perkins Coie was noted as counsel to Mylan, Teva and Akorn in the Law.com article, "Skilled in the Art: The Brave New World of Section 101 Guidance," which discusses whether Native American tribal immunity protects patents from inter partes review. -
04.19.2018Perkins Coie Team Noted as Counsel to Mylan in the Law360 Article - Allergan, Tribe Fight PTAB's Immunity Denial at Fed. Circ.General News
Law360
Perkins Coie attorney Brandon White was noted as counsel to Mylan in the Law360 article, “Allergan, Tribe Fight PTAB's Immunity Denial at Fed. Circ.,” regarding The Patent Trial and Appeal Board going against decades of U.S. Supreme Court precedent. -
03.26.2018Perkins Coie Team Noted as Counsel to Mylan in the Law360 Article - Generic Cos. Tell Fed. Circ. Not To Halt PTAB Restasis IPRsGeneral News
Law360
Perkins Coie attorneys Eric Miller, Charles Curtis, Andrew Dufresne, Shannon Bloodworth, Brandon White and Dan Bagatell were noted as counsel to Mylan in the Law360 article, "Generic Cos. Tell Fed. Circ. Not To Halt PTAB Restasis IPRs," regarding the Patent Trial and Appeal Board's review of patents. -
03.19.2018Perkins Coie Team Mentioned in Law360 - Tribe Asks Fed. Circ. To Pause Restasis Patent ReviewsGeneral News
Law360
The Perkins Coie team representing Mylan was mentioned in the Law360 article, “Tribe Asks Fed. Circ. To Pause Restasis Patent Reviews,” regarding the Federal Circuit being asked to stop the Patent Trial and Appeal Board’s review of certain patents. -
02.23.2018Perkins Coie Attorneys Recognized as Mylan Pharmaceuticals Representation in Law360 Article - Tribe Not Immune From Restasis IP Challenges, PTAB SaysGeneral News
Law360
Perkins Coie attorneys recognized as Mylan Pharmaceutical's representation in Law360 article, "Tribe Not Immune From Restasis IP Challenges, PTAB Says." -
09.28.2015Brandon M. White Mentioned in Law360 - Novartis Sclerosis Drug Patent Gets Axed In AIA ReviewGeneral News
Law360
Brandon M. White was mentioned as counsel for Mylan Inc. in a Law360 article, "Novartis Sclerosis Drug Patent Gets Axed In AIA Review," regarding the ruling against the Novartis Sclerosis drug patent. -
08.26.2015Brandon M. White Mentioned in Law360 - Mylan Nabs AIA Review Of 2 Patents For Teva's CopaxoneGeneral News
Law360
Brandon M. White was mentioned as counsel for Mylan Inc. in "Mylan Nabs AIA Review Of 2 Patents For Teva's Copaxone," a Law360 article, regarding the granted reviews of two patents licensed to Teva Pharmaceuticals USA Inc. for its multiple sclerosis drug Copaxone. -
06.18.2015Brandon M. White Mentioned in Law360 - Fed. Circ. Axes Teva MS Drug Patent In High Court RemandGeneral News
Law360
Brandon M. White was mentioned as counsel for Mylan Inc. in "Fed. Circ. Axes Teva MS Drug Patent In High Court Remand," a Law360 article, regarding the ruling on the patent on Teva Pharmaceutical Industries Ltd.'s multiple sclerosis drug Copaxone, naming it "invalid". -
09.05.2014Brandon M. White Mentioned in Law360 - Hospira Can't Block Generic Precedex, Judge RulesGeneral News
Law360
Brandon M. White was mentioned as counsel for Mylan Inc. in a Law360 article, "Hospira Can't Block Generic Precedex, Judge Rules," regarding the FDA's not approving the generic version of Precedex. -
08.26.2014Brandon M. White Mentioned in Law360 - Mylan Needn't Recall Generic Precedex In Battle With HospiraGeneral News
Law360
Brandon M. White was mentioned as counsel for Mylan Inc. in "Mylan Needn't Recall Generic Precedex In Battle With Hospira," a Law360 article, regarding the halted recall of Precedex. -
08.20.2014Perkins Coie Mentioned in Law360 - Mylan Wins Stay Of Generic Precedex Recall In Hospira RowGeneral News
Law360
Perkins Coie was mentioned as counsel for Mylan Inc. in "Mylan Wins Stay Of Generic Precedex Recall In Hospira Row," a Law360 article, regarding the halted recall of Precedex.
